Globally, tuberculosis (TB) is one of the top 10 causes of death. In 2017, 10 million people around the world became sick with TB, and 1.6 million people died from the disease, including 300,000 HIV-positive people according to the World Health Organization. Complicating this public health challenge is the growing number of drug-resistant cases. The international community has set specific goals in the End TB Strategy that call for a 95 percent reduction in deaths from TB and a 90 percent reduction in new cases by 2035 compared to 2015 figures. To meet these goals, it is critical to tap into private sector resources in addition to those of governments’.
SHOPS Plus supports national programs in controlling the spread of the disease and in providing quality patient care. The project uses private sector engagement as well as social and behavior change campaigns throughout the continuum of care to improve access to TB products and services.
In India, SHOPS Plus supports the Revised National TB Control Program’s social and behavior change strategy for stigma reduction, and improves access to diagnosis and treatment services by activating the integration of the National Urban Health Mission with the national TB program.
In Nigeria, SHOPS Plus is establishing private provider networks made up of clinical providers, patent medicine vendors, community pharmacists, and private laboratories to detect, diagnose, follow up, and treat TB. The networks are supported by the project through local intermediary organizations in collaboration with the national TB program and technology, such as its TB STARR digital app, which streamlines documentation and shortens the time to treatment of presumptive TB clients.